The WHO: Officially validated GLP-1 receptor agonists (semaglutide, tirzepatide and liraglutide) as effective treatments for obesity in adults with a BMI of 30 or more
References Pickart, L., Vasquez-Soltero, J
Nguyen HM, Ngoc Le TT, Nguyen AT, Thien Le HN, Pham TT
The key points to remember are: Mounjaro typically reduces systolic blood pressure by 7-10 mmHg and diastolic blood pressure by 4-5 mmHg in clinical trials Regular blood pressure monitoring is essential, especially during the first three months Work closely with your healthcare provider to adjust any existing blood pressure medications as needed Most blood pressure-related side effects are mild, with severe adverse events being rare The blood pressure benefits appear to persist as long as treatment continues If youre living with obesity and hypertension, a comprehensive approach that includes appropriate medication, dietary changes, regular physical activity, and stress management offers the best chance for long-term health improvements
All current evidence is from animal and cell studies there are no completed human trials for Dihexa itself
